(lp0
S'Albireo Pharma Inc. ALBO  Wall Street Journal - Feb 1, 2001 News Albireo Pharma Inc.ALBO. Significant News Only. 03/07/17; Press Release. Albireo to Host Conference Call and Webcast on March 14 at 8:30 a.m.'
p1
aS'BRIEF-Albireo Pharma Inc says filed for mixed shelf offering of up to $100 mln Reuters - Dec 22, 2016 BERLIN, Feb 12 Greece and its lenders should quickly approve a review of reforms the indebted country must take in return for unlocking new loans, a senior European Union official said on Sunday, warning of financial instability in the euro zone if the ...'
p2
aS'Q1 2017 EPS Estimates for Albireo Pharma, Inc. Cut by Analyst  Chaffey Breeze - Mar 19, 2017 Albireo Pharma logo Albireo Pharma, Inc.  - Analysts at William Blair cut their Q1 2017 EPS estimates for shares of Albireo Pharma in a research report issued on Tuesday.'
p3
aS'Albireo Pharma Inc  Moves into Overbought Territory Business Review - Mar 20, 2017 Checking on current RSI levels on shares of Albireo Pharma Inc , the 14-day RSI is currently standing at 70.53, pushing the stock into overbought territory.'
p4
aS"Albireo Completes Transaction with Biodel to Create Publicly Traded Company ... GlobeNewswire  - Nov 3, 2016 BOSTON, Nov. 03, 2016  -- Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators through its operating subsidiary, today announced the completion of the share exchange&nbsp;...Nine stories you may have missed Thursday from the world of business - The Boston GlobeBoston's newest public company, Albireo, aims to treat kids' liver diseases - Boston Business Journal"
p5
aS'Albireo Pharma Inc. MarketWatch - Nov 9, 2016 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p6
aS"Albireo Pharma Inc. - Receive News &amp; Ratings Daily BBNS - 15 hours ago Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albireo Pharma Inc. and related companies with MarketBeat.com's FREE daily ratings newsletter."
p7
aS'ALBIREO PHARMA, INC.  Files An 8-K Departure of Directors or ... Market Exclusive - Jan 27, 2017 On January 23, 2017, the Board of Directors  of Albireo Pharma, Inc. , acting upon the recommendation of the Compensation Committee of the Board , approved an increase in the annual base&nbsp;...'
p8
aS"William Blair Weighs in on Albireo Pharma, Inc.'s Q1 2017 Earnings  The Cerbat Gem - Mar 18, 2017 Albireo Pharma logo Albireo Pharma, Inc.  - Equities researchers at William Blair decreased their Q1 2017 earnings estimates for shares of Albireo Pharma in a research report issued to clients and investors on Tuesday."
p9
aS'Boston biotech Albireo goes public in unusual fashion The Boston Globe - Nov 3, 2016 Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company, in a deal that will leave Albireo with about $30 million to develop a treatment for a pediatric liver disease.'
p10
a.